Learn how SGLT2 inhibitor dapagliflozin improves MASH outcomes, with potential clinical use beyond diabetes care.

Based on remarks by former Bank Negara governor Muhammad Ibrahim, here are five reasons why this argument may not be as ...

With youth month around the corner, education support networks have raised the alarm on the persistent underperformance and ...

As Nigeria marks 26 years of uninterrupted democracy, counselor to the Kaduna State Governor on Infrastructure, Samaila ...

All right. That’s great. And then maybe if you guys could talk about the relative attractiveness in the primary versus secondary markets and kind of how the investment portfolio is positioned in ...

Wizz Air is one of Europe’s fastest-growing airlines; its passenger volume expanded from 10 million in 2011 to over 60 million in 2024. Growth is underpinned by a Ryanair-style low-cost model and a ...

Currently, the only approved treatment for MASH on the market is the thyroid hormone receptor β agonist resmetirom (Rezdiffra ...

Net Asset Value (NAV) per Share: $4.32 as of March 31, 2025, down from $4.82 in the previous quarter. Total Investment Income: $121.2 million for the quarter ended March, an increase of $6.7 ...

Main outcome measures The primary outcome measure was the reported recurrence of instability, that is, dislocation at 2-year follow-up. The secondary outcome measures included clinical apprehension, ...